...
首页> 外文期刊>Cancer Management and Research >Prognostic values of baseline, interim and end-of therapy 18 F-FDG PET/CT in patients with follicular lymphoma
【24h】

Prognostic values of baseline, interim and end-of therapy 18 F-FDG PET/CT in patients with follicular lymphoma

机译:滤泡性淋巴瘤患者基线,中期和结束治疗18 F-FDG PET / CT的预后价值

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: In the present study, we aimed to investigate the role of baseline, interim and end-of treatment positron emission tomography/computed tomography (PET/CT) in assessing the prognosis of follicular lymphoma (FL). Methods: A total of 84 FL patients were retrospectively analyzed in this study. Baseline (n=59), interim (n=24, after 2–4 cycles) and end-of treatment (n=43) PET/CT images were re-evaluated, and baseline maximum standardized uptake value (SUVsubmax/sub), total metabolic tumor volume (tMTV) and total lesion glycolysis (TLG) were recorded. Interim (I-PET) and end-of treatment (E-PET) PET/CT responses were interpreted by Deauville five-point scale (D-5PS) and International Harmonization Project criteria (IHP). Survival curves were calculated by Kaplan-Meier curves, and differences between groups were compared by log-rank test. Results: The 2-year progression-free survival (PFS) of the high- and low-TLG groups was 57.14% and 95.56%, respectively ( p =0.0001). The 2-year overall survival (OS) of the high- and low-TLG groups was 62.50% and 100%, respectively ( p 0.0001). Multivariate analysis showed that TLG was an independent prognostic factor for PFS ( p =0.001, HR=6.577, 95% CI=2.167–19.960) and OS ( p =0.030, HR=19.291, 95% CI =2.689–137.947). Besides, Eastern Cooperative Oncology Group (ECOG) was the independent prognostic factor for OS (HR=8.924, 95% CI=1.273–62.559, p =0.028). Interim PET results based on D-5PS or IHP criteria were not significantly correlated with PFS (all p 0.05). However, E-PET results using D-5PS and IHP criteria were statistically significant ( p =0.0001 and p =0.006). The D-5PS showed stronger prognostic value compared with IHP criteria. The optimal cutoff value of ΔSUVsubmax/sub% was 66.95% according to I-PET and 68.97% according to E-PET. However, only the ΔSUVsubmax/sub% from the baseline to the end-of therapy yielded statistically significant results in the prediction of PFS ( p =0.0002). Conclusion: Our findings indicated that the baseline TLG and E-PET results were significantly associated with prognosis in patients with FL.
机译:目的:在本研究中,我们旨在研究基线,中期和治疗后正电子发射断层扫描/计算机断层扫描(PET / CT)在评估滤泡性淋巴瘤(FL)的预后中的作用。方法:回顾性分析84例FL患者。重新评估基线(n = 59),中期(2-4周后,n = 24)和治疗结束(n = 43)PET / CT图像,并评估基线最大标准化摄取值(SUV max ),记录总代谢肿瘤体积(tMTV)和总病变糖酵解(TLG)。中期(I-PET)和治疗结束(E-PET)的PET / CT反应由多维尔五点量表(D-5PS)和国际协调项目标准(IHP)进行解释。通过Kaplan-Meier曲线计算存活曲线,并通过对数秩检验比较组之间的差异。结果:高和低TLG组的2年无进展生存期(PFS)分别为57.14%和95.56%(p = 0.0001)。高和低TLG组的2年总生存率(OS)分别为62.50%和100%(p <0.0001)。多因素分析显示,TLG是PFS(p = 0.001,HR = 6.077,95%CI = 2.167–19.960)和OS(p = 0.030,HR = 19.291,95%CI = 2.689–137.947)的独立预后因素。此外,东部合作肿瘤小组(ECOG)是OS的独立预后因素(HR = 8.924,95%CI = 1.273–62.559,p = 0.028)。基于D-5PS或IHP标准的中期PET结果与PFS无显着相关性(所有p> 0.05)。然而,使用D-5PS和IHP标准的E-PET结果具有统计学意义(p = 0.0001和p = 0.006)。与IHP标准相比,D-5PS的预后价值更高。根据I-PET,ΔSUV max %的最佳临界值为66.95%,根据E-PET为68.97%。但是,从基线到治疗结束仅ΔSUV max %在PFS预测中产生了统计学上显着的结果(p = 0.0002)。结论:我们的发现表明,基线TLG和E-PET结果与FL患者的预后显着相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号